Skip to main content
Erschienen in: International Urogynecology Journal 1/2007

01.01.2007 | Case Report

Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence

verfasst von: María-Teresa Castillo-Vico, Miguel A. Checa-Vizcaíno, Antonio Payà-Panadés, Carolina Rueda-García, Ramón Carreras-Collado

Erschienen in: International Urogynecology Journal | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Periurethral injection of bulk-enhancing agents provides a simpler and cost-effective therapeutic approach for stress incontinence in women. We report a case of periurethral granuloma secondary to dextranomer/hyaluronic acid (Dx/HA) copolymer injection. A 73-year-old woman with history of radiotherapy for cervical carcinoma at the age of 55 presented with stress urinary incontinence. She underwent periurethral injection of Dx/HA copolymer, and incontinence was resolved. At 4 months postoperatively, a 3–4 cm noninflammatory painless mass in the external genitalia was noted. Cystic images compatible with urethral diverticula were seen in the magnetic resonance imaging scan, but voiding cystourethrography was unrevealing. Transvaginal tumor puncture yielded abundant creamy material, the culture of which was negative. Microscopic examination revealed refractile foreign material surrounded by foreign body giant cells. Surgical debridement of the granuloma using a cold scalpel was performed. Stress urinary incontinence recurred but resolved spontaneously within 1 month. One year later, the patient continues to be asymptomatic.
Literatur
1.
Zurück zum Zitat Murless BC (1938) The injection treatment of stress incontinence. J Obstet Gynaecol Br Emp 45:67–73 Murless BC (1938) The injection treatment of stress incontinence. J Obstet Gynaecol Br Emp 45:67–73
2.
Zurück zum Zitat Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158:1937–1941PubMedCrossRef Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158:1937–1941PubMedCrossRef
3.
Zurück zum Zitat Stenberg A, Larsson E, Lindholm A, Ronneus B, Stenberg A, Lackgren G (1999) Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 33:355–361CrossRefPubMed Stenberg A, Larsson E, Lindholm A, Ronneus B, Stenberg A, Lackgren G (1999) Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 33:355–361CrossRefPubMed
4.
Zurück zum Zitat Badia Llach X, Castro Díaz D, Conejero Sugrañes J en nombre del Grupo King’s (2000) Validity of the King’s Health Questionnaire in the assessment of quality of life in patients with urinary incontinence. Med Clin (Barc) 114:647–652 (in Spanish) Badia Llach X, Castro Díaz D, Conejero Sugrañes J en nombre del Grupo King’s (2000) Validity of the King’s Health Questionnaire in the assessment of quality of life in patients with urinary incontinence. Med Clin (Barc) 114:647–652 (in Spanish)
5.
Zurück zum Zitat Alonso J, Prieto L, Anto JM (1995) The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 104:771–776 (in Spanish) Alonso J, Prieto L, Anto JM (1995) The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 104:771–776 (in Spanish)
6.
Zurück zum Zitat Stenberg A, Larsson E, Lackgren G (2003) Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 169:1109–1113CrossRefPubMed Stenberg A, Larsson E, Lackgren G (2003) Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 169:1109–1113CrossRefPubMed
7.
Zurück zum Zitat Schultz JA, Nager CW, Stanton SL, Baessler K (2004) Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J Pelvic Floor Dysfunct 15:261–265PubMed Schultz JA, Nager CW, Stanton SL, Baessler K (2004) Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J Pelvic Floor Dysfunct 15:261–265PubMed
8.
Zurück zum Zitat Su TH, Hsu CY, Chen JC (1999) Injection therapy for stress incontinence in women. Int Urogynecol J Pelvic Floor Dysfunct 10:200–206CrossRefPubMed Su TH, Hsu CY, Chen JC (1999) Injection therapy for stress incontinence in women. Int Urogynecol J Pelvic Floor Dysfunct 10:200–206CrossRefPubMed
9.
Zurück zum Zitat Appell RA (1994) Collagen injection therapy for urinary incontinence. Urol Clin North Am 21:177–182PubMed Appell RA (1994) Collagen injection therapy for urinary incontinence. Urol Clin North Am 21:177–182PubMed
10.
Zurück zum Zitat Echols KT, Chesson RR, Breaux EF, Shobeiri SA (2002) Persistence of delayed hypersensitivity following transurethral collagen injection for recurrent urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 13:52–54CrossRefPubMed Echols KT, Chesson RR, Breaux EF, Shobeiri SA (2002) Persistence of delayed hypersensitivity following transurethral collagen injection for recurrent urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 13:52–54CrossRefPubMed
11.
Zurück zum Zitat Stothers L, Goldenberg SL, Leone EF (1998) Complications of periurethral collagen injection for stress urinary incontinence. J Urol 159:806–807CrossRefPubMed Stothers L, Goldenberg SL, Leone EF (1998) Complications of periurethral collagen injection for stress urinary incontinence. J Urol 159:806–807CrossRefPubMed
12.
Zurück zum Zitat Theofrastous JP, Simpkins K (2002) Urinary retention and intravesical hemorrhage following urethral collagen injections in women using warfarin. Int Urogynecol J Pelvic Floor Dysfunct 13:268–269CrossRefPubMed Theofrastous JP, Simpkins K (2002) Urinary retention and intravesical hemorrhage following urethral collagen injections in women using warfarin. Int Urogynecol J Pelvic Floor Dysfunct 13:268–269CrossRefPubMed
13.
Zurück zum Zitat Su TH, Wang KG, Hsu CY, Wei HJ, Shien FC (1998) Periurethral fat injection in the treatment of recurrent genuine stress incontinence. J Urol 159:411–414PubMedCrossRef Su TH, Wang KG, Hsu CY, Wei HJ, Shien FC (1998) Periurethral fat injection in the treatment of recurrent genuine stress incontinence. J Urol 159:411–414PubMedCrossRef
Metadaten
Titel
Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence
verfasst von
María-Teresa Castillo-Vico
Miguel A. Checa-Vizcaíno
Antonio Payà-Panadés
Carolina Rueda-García
Ramón Carreras-Collado
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 1/2007
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-005-0049-7

Weitere Artikel der Ausgabe 1/2007

International Urogynecology Journal 1/2007 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.